Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: A conceivable alternative

Bone Marrow Transplantation

Volumn 20, Issue 11, 1997, Pages 939-944

  Borgmann, A ^a   Baumgarten, E ^a   Schmid, H ^a   Dopfer, R ^b   Ebell, W ^c   Gobel U ^d   Niethammer, D ^b   Gadner, H ^e   Henze, G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Acute lymphoblastic leukemia; Allogeneic bone marrow transplantation; Bone marrow relapse; Children

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION;

EID: 0030727389     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701013     Document Type: Article

References (35)

1. Rivera GK, Pinkel D, Simone JV er al. Treatment of acute lymphoblastic leukemia. 30 Years' experience at St Jude Children's Research Hospital. New Engl J Med 1993; 329: 1289-1295.
2. Chessels JM. Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects. Blood Rev 1992; 6: 193-203.
3. Reiter A, Schrappe M, Ludwig WD et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusion of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
4. Butturini A, Rivera GK, Bortin MM, Gale RP. Which treatment for childhood acute lymphoblastic leukaemia in second remission? Lancet 1987; 1: 429-432.
5. Borgmann A, Schmid H, Hartmann R et al. Autologous bone marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. Lancet 1995; 346: 873-876.
6. Pui CH, Bowman P, Ochs J et al. Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy. Med Pediatr Oncol 1988; 16: 21-26.
7. Uderzo C, Valsecchi MG, Bacigalupo A et al. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association. Clin Oncol 1995; 13: 352-358.
8. Sadowitz PD, Smith SD, Shuster J et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1993; 81: 602-609.
9. Henze G, Fengler R, Hartmann R. Chemotherapy for relapsed childhood acute lymphoblastic leukemia: results of the BFM Study Group. Haematol Blood Transfus 1994; 36: 374-379.
10. Henze G, Fengler R, Hartmann R et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group. Blood 1991; 78: 1166-1172.
11. Dopfer R, Henze G, Bender-Götze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood 1991; 78: 2780-2784.
12. Borgmann A, Hartmann R, Schmid H et al. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. Bone Marrow Transplant 1995; 15: 515-521.
13. Bührer C, Hartmann R, Fengler R et al. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1993; 21: 470-476.
14. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New Engl J Med 1994; 331: 1253-1258.
15. Sanders JE, Thomas ED, Buckner CD, Doney K. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987; 70: 324-326.
16. Ortega JJ, Olive T, Diaz De Heredia C et al. Comparison between allogeneic and autologous BMT in children with ALL. Med Pediatr Oncol 1993; 21: 557 (Abstr.).
17. Giese S, Wisniewski S, Berger K et al. Assessment of neuropsychological status after CNS relapse in childhood acute lymphoblastic leukemia. Blood 1995; 86 (Suppl. 1): 760 (Abstr.).
18. Wagner HP, Wagner B, Vonderweid N et al. Long-term survival of patients with relapsing ALL: a study of the Swiss Pediatric Oncology Group SPOG. Med Pediatr Oncol 1992; 20: 378 (Abstr.).
19. Christie D, Battin M, Leiper AD et al. Neuropsychological and neurological outcome after relapse of lymphoblastic leukaemia. Arch Dis Child 1994; 70: 275-280.
20. Kumar P, Mulhern RK, Regine WF et al. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia. Int J Radiat Oncol Biol Phys 1995; 31: 561-566.
21. Riehm H, Feickert HJ, Lampert F. Acute lymphoblastic leukemia. In: Voute PA, Barret A, Bloom HJG et al (eds). Cancer in Children: Clinical Management. Springer-Verlag: New York, 1986, p 101.
22. Henze G, Langermann HJ, Ritter J et al. Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: a report from the BFM Study Group. Haematol Blood Transfus 1981; 26: 87-93.
23. Janka GE, Winkler K, Jürgens H et al. Acute lymphoblastic leukemia in childhood: the COALL therapy studies. Klin Pädiatr 1986; 198: 171-177.
24. Janka-Schaub GE, Harms D, Göbel U el at. Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood - follow up after 9 years. Eur Pediatr 1996; 155: 640-648.
25. Henze G, Hartmann R, Fengler R. Salvage therapy of childhood ALL: prognosis of marrow relapse after intensive front-line therapy. Haematol Blood Transfus 1996; 37: 223-228.
26. Butturini A, Gale RP. Chemotherapy versus transplantation: II. Acute lymphoblastic leukemia. Haematologica 1989; 74: 337-339.
27. Butturini A, Gale RP. Chemotherapy versus transplantation in acute leukaemia. Br J Haematol 1989; 72: 1-8.
28. Ramsay NK. Bone marrow transplantation for acute lymphoblastic leukemia. Med Pediatr Oncol 1995; 25: 274 (Abstr.).
29. Moussalem M, Esperou Bourdeau H, Devergie A et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Bone Marrow Transplant 1995; 15: 943-947.
30. Niethammer D, Klingebiel T, Riehm H et al. Role and perspectives of BMT in ALL: the BFM experience. Bone Marrow Transplant 1991; 7 (Suppl. 3): 14-18.
31. Brochstein JA, Kernan NA, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leu-kemia. New Engl J Med 1987; 317: 1618-1624.
32. Bührer C, Hartmann R, Fengler R et al. Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. Blood 1994; 83: 3468-3472.
33. Sallan SE, Niemeyer CM, Billett AL et al Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol 1989; 7: 1594-1601.
34. Dopfer R, Niethammer D. Report on the International Workshop of the Kind Philipp Foundation on late effects after bone marrow transplantation in childhood malignancies. Pediatr Hematol Oncol 1993; 10: 63-84.
35. Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633-3639.